# Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Article · Juan P. Frías, Melanie Jane Davies, Julio Rosenstock, Federico Pérez Manghi, Laura Fernández Landó, Brandon K. Bergman, Bing Liu, Xuewei Cui, Katelyn E. Brown

- Archive id: doi:10.1056/nejmoa2107519
- Published: 2021-06-25
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2107519
- PMID: 34170647
- Citations: 2,086
- Source URL: https://doi.org/10.1056/nejmoa2107519
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.